Priftin (sanofi-aventis U.S. LLC)


Welcome to the PulseAid listing for the Priftin drug offered from sanofi-aventis U.S. LLC. This Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: sanofi-aventis U.S. LLC
NON-PROPRIETARY NAME: rifapentine
SUBSTANCE NAME: RIFAPENTINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1998-06-22
END MARKETING DATE: 0000-00-00


Priftin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPriftin from sanofi-aventis U.S. LLC
LABELER NAME: sanofi-aventis U.S. LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 1998-06-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0088-2100_cca47f54-0cbb-469d-8f05-bb2d35e6e3f5
PRODUCT NDC: 0088-2100
APPLICATION NUMBER: NDA021024

Other RIFAPENTINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
sanofi-aventis U.S. LLCPriftin